首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷 CT/MRI/X光

市場調查報告書

商品編碼

1741513

全球放射性示踪劑市場按類型、應用、最終用戶和地區分類

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計 2025 年全球放射性示蹤劑市場規模為 37.2 億美元，到 2032 年將達到 60.5 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.2%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	37.2億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	7.20%	2032年價值預測	60.5億美元

放射性示蹤劑已成為醫療保健、研究和石油探勘等各行各業的必備工具。這些示蹤劑由放射性物質組成，這些物質會發出易於檢測和測量的輻射。示踪劑用於追蹤特定分子的運動，研究各種生物過程，並識別地下蘊藏物的潛在來源。近年來，由於放射性示蹤劑在醫療診斷和治療以及環境和石化領域的應用不斷擴大，全球放射性追蹤劑市場經歷了顯著成長。

市場動態：

放射性示蹤劑市場受到多種因素的推動，包括技術進步、慢性病的增加、個人化醫療需求的增加等。由於正子斷層掃描 (PET) 和單光子發射電腦斷層掃描 (SPECT) 等診斷影像技術的日益普及，該市場正在經歷顯著成長，這些技術利用放射性示踪劑來檢測和分析各種疾病和狀況。

另一方面，挑戰包括與放射性物質使用和處置相關的嚴格法規。監管機構制定了嚴格的指導方針，以確保放射性示蹤劑的安全處理和處置，這顯著增加了生產成本，從而影響了市場成長。此外，熟練專業人員的匱乏以及核醫程序的高昂費用預計也會在一定程度上抑制市場成長。

儘管面臨這些挑戰，放射性示蹤劑市場仍充滿成長機會。放射性藥物製造技術的進步和新型放射性同位素的開發有望為市場參與者開闢新的發展途徑。此外，石油和天然氣探勘、環境監測和工業檢測等行業對放射性示蹤劑的日益普及也有望進一步推動市場成長。

本研究的主要特點

本報告對全球放射性示蹤劑市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和複合年成長率。
它還揭示了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
全球放射性示蹤劑市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球放射性示踪劑市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球放射性示蹤劑市場的各種策略矩陣來更輕鬆地做出決策。

PerkinElmer Inc.
Cardinal Health
Bracco
NTP Radioisotopes
Nordion（Canada）Inc.
Curium
IRE
Telix Pharmaceuticals Limited
NorthStar Medical Radioisotopes, LLC
Lantheus Holdings, Inc.
Eckert & Ziegler
Siemens Healthineers
GE Healthcare
Mallinckrodt Nuclear Medicine LLC
Jubilant DraxImage Inc.
Sumitomo Heavy Industries, Ltd.

第 10 章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI6389

Radioactive Tracer Market is estimated to be valued at USD 3.72 Bn in 2025 and is expected to reach USD 6.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.72 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.20%	2032 Value Projection:	USD 6.05 Bn

Radioactive tracers have become an essential tool in several industries, including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. They are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to the increasing applications of radioactive tracers in medical diagnostics and treatment, as well as in the environmental and petrochemical sectors.

Market Dynamics:

The radioactive tracer market is driven by several factors, including technological advancements, increasing prevalence of chronic diseases, and the growing demand for personalized medicine. The market is witnessing significant growth due to the rising adoption of diagnostic imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), which utilize radioactive tracers to detect and analyze various diseases and conditions.

On the other hand, the market faces certain challenges, such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, which significantly increases the cost of production and affects market growth. Additionally, the limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain market growth to some extent.

Despite these challenges, the radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new avenues for market players. Moreover, the increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is anticipated to drive market growth further.

Key features of the study:

This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global radioactive tracer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include PerkinElmer, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, NTP Radioisotopes, JSC Isotope, ANSTO, Nordion, Curium Pharma, and IRE
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market

Detailed Segmentation:

By Type
- Diagnostic Radioactive Tracers
- Therapeutic Radioactive Tracers
- Others
By Application
- Oncology
- Cardiology
- Neurology
- Thyroid
- Lymphoma
- Endocrinology
- Others
By End User
- Hospitals
- Diagnostic Centers
- Cancer Research Institutes
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- PerkinElmer
- Cardinal Health
- Lantheus Medical Imaging
- Bracco Imaging
- NTP Radioisotopes
- JSC Isotope
- ANSTO
- Nordion
- Curium Pharma
- IRE

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market, Radioactive Tracer, By Type
- Market Radioactive Tracer, By Application
- Market Radioactive Tracer, By End User
- Market Radioactive Tracer, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of chronic diseases
- Short half-life of radiopharmaceuticals
- Emerging applications in oncology
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Radioactive Tracer Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Radioactive Tracer Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Therapeutic Radioactive Tracers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Radioactive Tracer Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Thyroid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Radioactive Tracer Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Radioactive Tracer Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,( US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bracco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NTP Radioisotopes
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Nordion (Canada) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Curium
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IRE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Telix Pharmaceuticals Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
NorthStar Medical Radioisotopes, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lantheus Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eckert & Ziegler
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mallinckrodt Nuclear Medicine LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Jubilant DraxImage Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sumitomo Heavy Industries, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views